Status:
COMPLETED
Resuscitation and Capillary Reperfusion
Lead Sponsor:
Medical University of Vienna
Conditions:
Cardiac Arrest
Cardiac Arrest, Out-Of-Hospital
Eligibility:
All Genders
18-95 years
Brief Summary
Persistent microperfusion alterations after return of spontaneous circulation (ROSC) are associated with poor survival. To our knowledge, no human studies evaluating microperfusion during cardiopulmon...
Eligibility Criteria
Inclusion
- All patients ≥18 years during cardiopulmonary resuscitation
- witnessed cardiac arrest
Exclusion
- insufficient manpower (e.g. study team has to provide CPR)
- hypovolemia (exsanguination, anaphylaxis, sepsis as underlying cause)
- presumed or known COVID-19 disease
- hypo-/hyperthermia (\<36.0°, \>37.5°C)
- Raynaud's disease
- Peripheral arterial disease
Key Trial Info
Start Date :
March 3 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04791995
Start Date
March 3 2021
End Date
May 1 2022
Last Update
September 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vienna Municipal Emergency Service
Vienna, Austria